You can buy or sell PIRS and other stocks, options, ETFs, and crypto commission-free!
Pieris Pharmaceuticals, Inc. Common Stock, also called Pieris Pharmaceuticals, is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Read More Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.
52 Week High
52 Week Low
— per share
Expected May 7, Pre-Market